drugset / Trial / NCT01655641

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

NCT01655641

RandomizedParallel-groupTriple-blindTreatment

Summary

Primary objective of the study is to compare requirement of blood transfusion and mortality in patients receiving Tranexamic acid (Cyklokapron®) and those not receiving it. Secondary objective is to; assess the re-bleeding events; need for surgical intervention; length of stay in Intensive care unit in between the two groups.

Timeline

Start
2012-07
Primary completion
2013-06
Completion
2014-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 5 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous